Purchases and Sales Made in Q2 2021 in Nls Pharmaceutics Ltd. (NLSP)
This table provides information about the institutional ownership of Nls Pharmaceutics Ltd. (NLSP) during Q2 2021. The information is specifically focused on institutions that hold shares of NLS Pharmaceutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
42KNew |
$122K - $173K
|
42K
$79.4K
|
|
|
Aug 16, 2021
Q2 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
10.8KNew |
$31.4K - $44.5K
|
10.8K
$20.4K
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
BUY
|
- |
1.93KNew |
$5.6K - $7.93K
|
1.93K
$3.64K
|
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 12, 2021
Q2 2021
|
Clearstead Advisors, LLC
Cleveland, OH |
SELL
|
- |
-300Closed |
$873 - $1.24K
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-36.5KClosed |
$106K - $150K
|
0
$0
|